Thursday, 28 March 2019

Health provider terminates contract to run Northampton surgery

Health provider terminates contract to run Northampton surgery The alliance in charge of a Northampton surgery has announced it is terminating its contract, leaving the NHS to find a new provider.

Nene Clinical Commissioning Group (CCG) and NHS England are seeking another party to run Kings Heath Practice after the Northampton-based GP Alliance decided to pull out. Northampton Chronicle and Echo

The tipping point: considering the impact of the proposed changes to treatment waiting time targets

The tipping point: considering the impact of the proposed changes to treatment waiting time targets The totemic 18 week target for planned care is facing a radical overhaul. Jessica Morris breaks down what a change would mean for hospitals and patients. Nuffield Trust

50 years of NHS inquiries: Why they matter and what we can learn from them

50 years of NHS inquiries: Why they matter and what we can learn from them It is fifty years since what most people think of as the first NHS inquiry – into failures in care at Ely Hospital in Cardiff. The inquiry was set up in 1967 to investigate allegations of ill-treatment, the abuse of patients and theft by staff at the long-stay psychiatric hospital. The Health Foundation

1 million Brits at risk after missing vital inhaler check

1 million Brits at risk after missing vital inhaler check More than a million people with asthma in the UK could be at risk of a potentially life-threatening asthma attack because they did not get their inhaler technique checked by their GP or asthma nurse, according to new estimates by Asthma UK.

Nearly 1 in 5 (19%) people aren’t getting their inhaler technique checked, according to Asthma UK’s report, which included a survey of more than 10,000 people with asthma. This is an essential part of basic asthma care that everyone with asthma should be getting.

See also:

NHS joint working with industry is out of public sight

NHS joint working with industry is out of public sight NHS organisations are entering into working partnerships with drug companies, but the details, and even existence, of many of these deals are not being made available to the public, a BMJ investigation has found.

With government encouragement, the number of “joint working arrangements” is growing in England, and they brought more than £7.5m (€8.7m; $9.9m) into the health service in 2016 and 2017. Examples include several projects to review the medications of people with attention-deficit/hyperactivity disorder and more than 20 that focus on patients with age-related macular degeneration. But many of these agreements ignore official guidance that urges openness and transparency. The BMJ

See also:

Life expectancy drops among poorer women in England

Life expectancy drops among poorer women in England The life expectancy of women living in the poorest areas of England fell by 100 days in recent years, Office for National Statistics data suggests.

Between 2012-2014 and 2015-2017, female life expectancy in the richest areas increased by 84 days, widening the gap between rich and poor by half a year.

In men, the gap also widened - but less markedly.

Life expectancy in the UK as a whole has stopped improving at the rate expected, the ONS said. BBC News

See also:

Take over pharma to create new medicines, says top adviser

Take over pharma to create new medicines, says top adviser Part of the drugs industry should be taken over to make new antibiotics, an influential economist has argued.

Lord Jim O'Neill, who advised the government on antibiotic resistance, said he was shocked by pharmaceutical companies failing to tackle drug-resistant infections.

He said the solution may be to "just take it away from them and take it over".

The pharmaceutical industry said it was not standing still on the issue. BBC News

600 years’ supply of cystic fibrosis drug destroyed in price row

600 years’ supply of cystic fibrosis drug destroyed in price row 8,000 packs of Orkambi go out of date during standoff between maker and NHS

Nearly 8,000 packs of Orkambi, the breakthrough medicine for cystic fibrosis, have been destroyed by the manufacturer while it has been in a stand-off with the NHS over the high price it wants to charge for the drug.

The US company Vertex has distributed 80,000 packs of Orkambi around Europe from its base in the UK since the drug was licensed in 2015. Other European countries with smaller numbers of people affected by the genetic disease have agreed to a high price, sometimes in order to give access to patients before negotiating downwards. The Guardian

U-turn over plans to privatise cancer scanning services

U-turn over plans to privatise cancer scanning services PET-CT scanners to remain at Churchill hospital, Oxford, and be operated by NHS staff

NHS bosses have made a significant U-turn over plans to privatise cancer scanning services after outcry from MPs, doctors and patients.

The rethink means the two scanners used for the tests at the cancer centre at the Churchill hospital in Oxford will remain there, after the new private contractor was forced to drop plans to move them elsewhere. The Guardian

More than 50 bowel surgery patients should not have been operated on by well-known doctor, hospital admits

More than 50 bowel surgery patients should not have been operated on by well-known doctor, hospital admits More than 50 patients who were given a controversial form of bowel surgery by a well-known surgeon should not have been operated on, a hospital trust has admitted.

Dozens of women say they were left in severe pain after pelvic floor surgery using artificial mesh at Southmead Hospital in Bristol.

Tony Dixon, one of Britain's best known surgeons in the area, was suspended in 2017 after concerns were first raised and an inquiry examined 143 cases. The Daily Telegraph

See also:

Psychosis more common in 'people living in areas plagued by pollution'

Psychosis more common in 'people living in areas plagued by pollution' Living in a polluted city could raise the risk of psychosis, according to a study.

Scientists have for the first time linked toxic air to intense paranoia and hearing voices in young people.

The researchers warned this could develop into psychotic disorders, such as schizophrenia or bipolar, mental health problems and suicide attempts. The Daily Mail

See also: